Detection of myocardial fibrosis in patients with hypertrophic cardiomyopathy evaluated by biological markers

被引：0
|
作者：
Zaroui, A. [1 ]
Asmi, M. [1 ]
Tejelbenet, C. [1 ]
Ben Said, R. [1 ]
Kaabachi, N. [1 ]
Mourali, M. S. [1 ]
Mechmeche, R. [1 ]
机构：
[1] La Rabta Teaching Hosp, Tunis, Tunisia
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P850
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [31] Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction
    Yumin Li
    Jia Liu
    Yukun Cao
    Xiaoyu Han
    Guozhu Shao
    Xiaoyue Zhou
    Jin Gu
    Tong Liu
    Yue Cui
    Heshui Shi
    Scientific Reports, 11
  • [32] Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction
    Li, Yumin
    Liu, Jia
    Cao, Yukun
    Han, Xiaoyu
    Shao, Guozhu
    Zhou, Xiaoyue
    Gu, Jin
    Liu, Tong
    Cui, Yue
    Shi, Heshui
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [33] Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk
    Ashkir, Z.
    Samat, A. H. A.
    Ariga, R.
    Finnigan, L. E. M.
    Jermy, S.
    Akhtar, M. A.
    Sarto, G.
    Murthy, P.
    Wong, B. W. Y.
    Cassar, M. P.
    Beyhoff, N.
    Wicks, E. C.
    Thomson, K.
    Mahmod, M.
    Tunnicliffe, E. M.
    Neubauer, S.
    Watkins, H.
    Raman, B.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 26 (02) : 218 - 228
  • [34] Does the progression of myocardial fibrosis lead to atrial fibrillation in patients with hypertrophic cardiomyopathy?
    Yamaji, K
    Fujimoto, S
    Yutani, C
    Ikeda, Y
    Mizuno, R
    Hashimoto, T
    Nakamura, S
    CARDIOVASCULAR PATHOLOGY, 2001, 10 (06) : 297 - 303
  • [35] Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy
    Nakamori, Shiro
    Rowin, Ethan J.
    Rodriguez, Jennifer
    Ngo, Long H.
    Manning, Warren J.
    Maron, Martin
    Nezafat, Reza
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2024, 26 (02)
  • [36] Predictors as exercise intolerance and myocardial fibrosis of clinical outcomes in patients with hypertrophic cardiomyopathy
    Hwang, J. W.
    Kim, S. U. N. G. M.
    Park, S. U. N. G. -J.
    Kim, E. U. N. K.
    Chang, S. U. N. G. -A.
    Lee, S. A. N. G. -C.
    Choe, Y. E. O. N. H.
    Park, S. W. O. O.
    Kim, D. A. R. A. E.
    Choi, J. I. N. -O. H.
    Kim, H. A. J.
    Ok, S. E. O. N. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1913 - 1913
  • [37] The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Hancioglu, Emirhan
    Ozcan, Sevgi
    Donmez, Esra
    Terzioglu, Cemal
    Kirankaya, Ayseguel
    Tenekecigil, Aslihan
    Okuyan, Ertugrul
    Sahin, Irfan
    BIOMARKERS IN MEDICINE, 2025, 19 (06) : 187 - 195
  • [38] Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy
    Maron, Martin S.
    Chan, Raymond H.
    Kapur, Navin K.
    Jaffe, Iris Z.
    McGraw, Adam P.
    Kerur, Raj
    Maron, Barry J.
    Udelson, James E.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (07): : 837 - 841
  • [39] The relationship between serum lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Hancioglu, E.
    Ozcan, S.
    Donmez, E.
    Okuyan, E.
    Sahin, I
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
    Razi Khan
    David Massel
    David Scholl
    John Stiratt
    Gerald Wisenberg
    R Terry Thompson
    Frank Prato
    Derek Boughner
    Maria Drangova
    James A White
    Journal of Cardiovascular Magnetic Resonance, 13 (Suppl 1)
12345